Emergence of CXCR4-Using Human Immunodeficiency Virus Type 1 (HIV-1) Variants in a Minority of HIV-1-Infected Patients following Treatment with the CCR5 Antagonist Maraviroc Is from a Pretreatment CXCR4-Using Virus Reservoir

Antagonists of the human immunodeficiency virus type 1 (HIV-1) coreceptor, CCR5, are being developed as the first anti-HIV agents acting on a host cell target. We monitored the coreceptor tropism of circulating virus, screened at baseline for coreceptor tropism, in 64 HIV-1-infected patients who rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Westby, Mike, Lewis, Marilyn, Whitcomb, Jeannette, Youle, Mike, Pozniak, Anton L., James, Ian T., Jenkins, Tim M., Perros, Manos, van der Ryst, Elna
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2006
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1472081/
https://ncbi.nlm.nih.gov/pubmed/16641282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.80.10.4909-4920.2006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados